Serum lipidomics meets cardiac magnetic resonance imaging: Profiling of subjects at risk of dilated cardiomyopathy

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Sysi Aho, Marko ^a   Koikkalainen, Juha ^a   Seppänen Laakso, Tuulikki ^a   Kaartinen, Maija ^b   Kuusisto, Johanna ^c   Peuhkurinen, Keijo ^c   Kärkkäinen, Satu ^c   Antila, Margareta ^b   Lauerma, Kirsi ^b   Reissell, Eeva ^b   Jurkko, Raija ^b   Lötjönen, Jyrki ^a   Heliö, Tiina ^b   Orešič, Matej ^a  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LAMIN A; LAMIN C; LIPIDOME; MOLECULAR MARKER; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIAC IMAGING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FATTY ACID DESATURATION; FEMALE; GENE DELETION; GENETIC ASSOCIATION; HEART VOLUME; HETEROZYGOTE; HUMAN; IMAGE ANALYSIS; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPIDOMICS; LIPODYSTROPHY; MALE; MASS SPECTROMETRY; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; RISK ASSESSMENT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; AGED; BLOOD; CASE CONTROL STUDY; GENETICS; METHODOLOGY; MIDDLE AGED; MUTATION; PREDICTIVE VALUE; RISK; STANDARD;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; HUMANS; LAMIN TYPE A; LIPIDS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK; YOUNG ADULT;

EID: 79251636741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015744     Document Type: Article

References (22)

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, et al. (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29: 270-276.
2. Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, et al. (2003) Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 41: 771-780.
3. Mestroni L, Taylor MR (2008) Lamin A/C gene and the heart: how genetics may impact clinical care. J Am Coll Cardiol 52: 1261-1262.
4. Karkkainen S, Reissell E, Helio T, Kaartinen M, Tuomainen P, et al. (2006) Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Heart 92: 524-526.
5. Lin F, Worman HJ (1993) Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 268: 16321-16326.
6. Worman HJ, Fong LG, Muchir A, Young SG (2009) Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 119: 1825-1836.
7. Malhotra R, Mason PK (2009) Lamin A/C deficiency as a cause of familial dilated cardiomyopathy. Curr Opin Cardiol 24: 203-208.
8. Nadeau M, Noel S, Laberge PY, Hurtubise J, Tchernof A (2010) Adipose tissue lamin A/C messenger RNA expression in women. Metabolism 59: 1106-1114.
9. Koikkalainen JR, Antila M, Lotjonen JM, Helio T, Lauerma K, et al. (2008) Early familial dilated cardiomyopathy: identification with determination of disease state parameter from cine MR image data. Radiology 249: 88-96.
10. Oresic M, Simell S, Sysi-Aho M, Näntö-Salonen K, Seppänen-Laakso T, et al. (2008) Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 205: 2975-2984.
11. Garg A, Agarwal AK (2009) Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta 1791: 507-513.
12. Yamashita T, Yamashita K, Kamimura R (2007) A stepwise AIC method for variable selection in linear regression. Commun Stat Theory Methods 36: 2395-2403.
13. Castelo R, Roverato A (2009) Reverse engineering molecular regulatory networks from microarray data with qp-graphs. J Comp Biol 16: 213-227.
14. Karkkainen S, Helio T, Miettinen R, Tuomainen P, Peltola P, et al. (2004) A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy. Eur Heart J 25: 885-893.
15. Roe CR, Sweetman L, Roe DS, David F, Brunengraber H (2002) Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 110: 259-269.
16. Warensjo E, Smedman A, Stegmayr B, Hallmans G, Weinehall L, et al. (2009) Stroke and plasma markers of milk fat intake-a prospective nested case-control study. Nutr J 8: 21.
17. Pasotti M, Klersy C, Pilotto A, Marziliano N, Rapezzi C, et al. (2008) Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 52: 1250-1260.
18. Lotjonen J, Kivisto S, Koikkalainen J, Smutek D, Lauerma K (2004) Statistical shape model of atria, ventricles and epicardium from short- and long-axis MR images. Med Image Anal 8: 371-386.
19. Oresic M, Simell S, Sysi-Aho M, Nanto-Salonen K, Seppanen-Laakso T, et al. (2008) Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 205: 2975-2984.
20. Katajamaa M, Oresic M (2005) Processing methods for differential analysis of LC/MS profile data. BMC Bioinformatics 6: 179.
21. Katajamaa M, Miettinen J, Oresic M (2006) MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 22: 634-636.
22. Zou H, Hastie T (2005) Regularization and variable selection via the elastic net. J R Statist Soc B 67: 301-320.